Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1999
11/23/1999US5989535 Polymeric bioadhesive emulsions and suspensions and methods of treatment
11/23/1999US5989463 Methods for fabricating polymer-based controlled release devices
11/23/1999CA2154898C Stable sulfide compositions, uses, and process for preparation thereof
11/23/1999CA2148109C 1.alpha., 24-(oh)2-v.d.3 emulsion composition
11/23/1999CA2103680C Improved blood substitute
11/23/1999CA2015919C Cleaning compositions
11/23/1999CA2006184C Prolonged release composition based on trimebutine and process for the preparation thereof
11/23/1999CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments
11/22/1999CA2238257A1 Endocytosis of amf-r and uses thereof in cancer therapy
11/18/1999WO1999058694A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
11/18/1999WO1999058656A2 Sustained dna delivery from structural matrices
11/18/1999WO1999058651A1 Size enhanced fibrinolytic enzymes
11/18/1999WO1999058575A1 Aloe pectins
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/18/1999WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
11/18/1999WO1999058569A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)
11/18/1999WO1999058152A1 Cationic lipids with disulphide bonds for the intracellular delivery of therapeutic substances
11/18/1999WO1999058151A2 Synthetic polyaminoacid complexes for delivery of nucleic acids to target cells
11/18/1999WO1999058132A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis
11/18/1999WO1999058129A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
11/18/1999WO1999058115A1 Antidepressant therapy
11/18/1999WO1999058114A1 Sustained release tablets, additive compositions therefor and process for producing the same
11/18/1999WO1999058110A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999WO1999058109A1 Biologically active composition
11/18/1999WO1999058108A1 Biologically active composition
11/18/1999WO1999058104A1 Therapeutic compositions
11/18/1999WO1999058100A1 Cosmetic product
11/18/1999WO1999052562A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
11/18/1999WO1999051271A3 Compositions comprising glycol derivatives and alcohols
11/18/1999WO1999051202A3 Quinolone containing liposomes and their use as antibacterial agents
11/18/1999WO1999049895A3 Method for increasing the permeability of horny human tissue
11/18/1999WO1999049846A3 Compositions containing microparticles of water-insoluble substances and method for their preparation
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999042134A8 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
11/18/1999WO1999036099A8 Sustained release compositions, process for producing the same and utilization thereof
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821951A1 Orally administered solid or liquid cyclosporin compositions
11/18/1999DE19821731A1 Cosmetic agent containing crosslinked water-soluble or water-dispersible polyurethane(s) useful especially as hair treatment agent
11/18/1999CA2332110A1 Biologically active composition
11/18/1999CA2331840A1 Polymeric system for delivery of nucleic acid material to target cells in biological systems
11/18/1999CA2331542A1 Antidepressant therapy
11/18/1999CA2331501A1 Therapeutic compositions
11/18/1999CA2331350A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999CA2330859A1 Size enhanced fibrinolytic enzymes
11/18/1999CA2330741A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
11/18/1999CA2325636A1 Oral medicinal forms with reproducible release of the active ingr edient gatifloxacin or its pharmaceutically acceptable salts or hydrates
11/17/1999EP0957112A2 Low-substituted hydroxypropyl cellulose and process for producing same
11/17/1999EP0956859A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
11/17/1999EP0956337A1 Compositions and methods relating to the production, isolation, and modification of gas vesicles
11/17/1999EP0956301A2 Il-12 gene expression and delivery systems and uses
11/17/1999EP0956053A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
11/17/1999EP0956050A1 Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy
11/17/1999EP0956049A2 Conjugates of thrombin inhibitors and endogenes carriers
11/17/1999EP0956048A1 Stable compositions containing biologically active components
11/17/1999EP0956047A1 New carrier systems
11/17/1999EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
11/17/1999EP0956035A1 Oral cyclosporin formulations
11/17/1999EP0956026A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
11/17/1999EP0956014A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
11/17/1999EP0956010A1 Pharmaceutical microspheres of valproic acid for oral administration
11/17/1999EP0956006A1 Colonic delivery of weak acid drugs
11/17/1999EP0956004A2 Method for producing shaped and unshaped polyol masses
11/17/1999EP0956001A1 PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY
11/17/1999EP0956000A1 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
11/17/1999EP0955999A1 Novel liposome complexes for increased systemic delivery
11/17/1999EP0955997A1 Compositions for topical use containing polysaccharide sulphates
11/17/1999EP0880352B1 Stabilization of naloxone hydrochloride
11/17/1999EP0762898B1 Cyclodextrin cellular delivery system for oligonucleotides
11/17/1999EP0656026B1 Polyarylates containing derivatives of the natural amino acid l-tyrosine
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235552A Beta-glucan products and extration from cereals thereof
11/17/1999CN1235544A Controlled release dosage form of R-(Z)-alpha-methoxyimino-alpha-(1-azabicyclo 2,2 oct-c-yl) acetonitrile monohydrochloride
11/17/1999CN1235539A Substituted amylose as matrix for sustained drug release
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235150A Hydroxy-methyl-hexanones
11/17/1999CN1046516C Method for stabilizing compound DX-52-1 and lyophilized composiiton thereof
11/16/1999US5986090 Metallized porphyrins
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986043 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
11/16/1999US5985941 Blends, homogenizing to form emulsions
11/16/1999US5985916 Polymer-platinum compounds
11/16/1999US5985889 Dosage forms and method for ameliorating male erectile dysfunction
11/16/1999US5985860 System for transdermal delivery of pain relieving substances
11/16/1999US5985854 Prodrugs with enhanced penetration into cells
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985826 Methods of using hepatic-directed compounds in pretargeting strategies
11/16/1999US5985573 Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
11/16/1999US5985329 Particulate foods and pharmaceuticals coated with water-soluble hemicellulose
11/16/1999US5985322 Enteric administering of pellet with fluoxetine core and hydroxypropylmethyl cellulose acetate succinate layer; side effect reduction
11/16/1999US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors
11/16/1999US5985316 Composition and method of enhancing electrotransport agent delivery
11/16/1999US5985312 Methods and compositions for enhancing the bioadhesive properties of polymers
11/16/1999US5985311 Estrogen, a gestagen or androgen, acrylate adhesive and, as resorption promoters, oleic acid and 2-(2-ethoxyethoxy)ethanol.
11/16/1999US5985310 Chelating agent and an antimicrobial preservative which is boric acid and a compound selected from benzalkonium halide compounds, polymeric quaternary ammonium compounds, and quatemary ammonium alkylene glycol phospholipid derivatives
11/16/1999US5985300 Pore cleansing
1 ... 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 ... 1712